High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$493K
$493,587
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
NGNE
S
Neurogene Inc.
Jordan Julie
• Officer • Chief Medical Officer
Sell to Cover
2026-03-26
$18,128
|
||||||
| NGNE |
Neurogene Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-03-26 | $18,128 | S | Form 4 |
| NGNE |
Neurogene Inc.
|
CFO
Sell to Cover
|
2026-03-26 | $55,316 | S | Form 4 |
| NGNE |
Neurogene Inc.
|
CEO
Sell to Cover
|
2026-03-26 | $73,995 | S | Form 4 |
| NGNE |
Neurogene Inc.
|
CFO
Sell to Cover
|
2026-03-13 | $5,791 | S | Form 4 |
|
NGNE
S
Neurogene Inc.
Cobb Stuart
• Officer • Chief Scientific Officer
10b5-1 SellΔOwn -10.7%
2026-03-13
$81,456
|
||||||
| NGNE |
Neurogene Inc.
|
Officer • Chief Scientific Officer
10b5-1 SellΔOwn -10.7%
|
2026-03-13 | $81,456 | S | Form 4 |
|
NGNE
S
Neurogene Inc.
Cobb Stuart
• Officer • Chief Scientific Officer
10b5-1 Sell
2026-03-13
$3,268
|
||||||
| NGNE |
Neurogene Inc.
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2026-03-13 | $3,268 | S | Form 4 |
|
NGNE
S
Neurogene Inc.
Cobb Stuart
• Officer • Chief Scientific Officer
10b5-1 Sell
2026-03-13
$56,722
|
||||||
| NGNE |
Neurogene Inc.
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2026-03-13 | $56,722 | S | Form 4 |
| NGNE |
Neurogene Inc.
|
CFO
Sell to Cover
|
2026-03-13 | $48,748 | S | Form 4 |
| NGNE |
Neurogene Inc.
|
CFO
Sell to Cover
|
2026-03-13 | $29,637 | S | Form 4 |
| NGNE |
Neurogene Inc.
|
CFO
10b5-1 Sell
|
2026-02-27 | $120,526 | S | Form 4 |